Quick Answer
Cardlytics, Inc. reported Diluted EPS of $1.95 per share (loss) for fiscal year 2025.
Cardlytics, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | -$1.95 | +50.1% |
| 2024 | -$3.91 | -6.0% |
| 2023 | -$3.69 | +73.5% |
| 2022 | -$13.92 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$1.36 | +53.1% | -655.6% |
| June 30, 2025 | -$0.18 | -100.0% | +30.8% |
| March 31, 2025 | -$0.26 | +53.6% | +91.0% |
| September 30, 2024 | -$2.90 | -360.3% | -3122.2% |
| June 30, 2024 | -$0.09 | +86.6% | +83.9% |
| March 31, 2024 | -$0.56 | -240.0% | +11.1% |
| September 30, 2023 | -$0.63 | -431.6% | +6.0% |
| June 30, 2023 | -$0.67 | +82.1% | -267.5% |
- Cardlytics, Inc. showed an increase of +50.1% in Diluted EPS compared to the prior fiscal year.
- Over the 2022–2025 period, Cardlytics, Inc.’s diluted eps has grown by 86.0% (from $13.92 per share (loss) to $1.95 per share (loss)).
- The most recent figure is from Cardlytics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: